Back to search
FDAFDA · Food and drugs·Recall number D-0866-2023

Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only, Distributed by: Meda pharmaceuticals Inc. (a Viatris company) Somerset New Jersey 00873-4120, NDC #0037-9001-05

Published June 14, 2023 · Recall initiated: May 25, 2023

Summary

FDA records drug Class II recall D-0866-2023, published June 14, 2023 and initiated May 25, 2023. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 2,736 boxes; Lot: Lot #: 101241A, Exp 10/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Viatris Inc
Distributor
Product was distributed to 10 distributors who may have further distribute the product to the retail level.
Lot
Lot #: 101241A, Exp 10/23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only, Distributed by: Meda pharmaceuticals Inc. (a Viatris company) Somerset New Jersey 00873-4120, NDC #0037-9001-05 recalled?

Yes. FDA published recall D-0866-2023 on June 14, 2023. Reported hazard: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

What should I do if I have this product?

Voluntary: Firm initiated · Letter